Press Releases : BioMarin https://investors.biomarin.com/ BioMarin and Believe Limited Announce the Debut of 'Hemophilia: The Musical' https://investors.biomarin.com/press-releases?item=587 First-of-its-Kind Musical Featuring 25 High-School Students Affected by Bleeding Disorders Premieres in Broadway Theater Mon, 12 Nov 2018 13:10:00 -0800 https://investors.biomarin.com/press-releases?item=587 BioMarin to Participate in Two Investor Conferences in November https://investors.biomarin.com/2018-11-08-BioMarin-to-Participate-in-Two-Investor-Conferences-in-November - Credit Suisse 27th Annual Credit Suisse Healthcare Conference on November 13 in Scottsdale, AZ Thu, 08 Nov 2018 05:30:00 -0800 https://investors.biomarin.com/2018-11-08-BioMarin-to-Participate-in-Two-Investor-Conferences-in-November BioMarin Highlights Breadth of Innovative Development Pipeline at R&D Day on November 7th in New York https://investors.biomarin.com/2018-11-07-BioMarin-Highlights-Breadth-of-Innovative-Development-Pipeline-at-R-D-Day-on-November-7th-in-New-York Vosoritide for Achondroplasia: Demonstrates Continued Increased Growth through 42 months in Phase 2; Global Phase 3 Fully Enrolled Wed, 07 Nov 2018 06:10:00 -0800 https://investors.biomarin.com/2018-11-07-BioMarin-Highlights-Breadth-of-Innovative-Development-Pipeline-at-R-D-Day-on-November-7th-in-New-York BioMarin to Highlight Breadth of Innovative Development Pipeline at R&D Day on November 7th in New York https://investors.biomarin.com/2018-11-01-BioMarin-to-Highlight-Breadth-of-Innovative-Development-Pipeline-at-R-D-Day-on-November-7th-in-New-York Key Research & Development Pipeline Products and Data to be Presented, Including: Thu, 01 Nov 2018 05:30:00 -0700 https://investors.biomarin.com/2018-11-01-BioMarin-to-Highlight-Breadth-of-Innovative-Development-Pipeline-at-R-D-Day-on-November-7th-in-New-York BioMarin Announces Third Quarter 2018 Results https://investors.biomarin.com/2018-10-25-BioMarin-Announces-Third-Quarter-2018-Results - First Nine Months of 2018 Total Revenues Grow 19% Year-over-year to $1.14 Billion Thu, 25 Oct 2018 13:05:00 -0700 https://investors.biomarin.com/2018-10-25-BioMarin-Announces-Third-Quarter-2018-Results